
pmid: 31174839
DUX4, a double homeobox transcription factor, has been mostly studied in facioscapulohumeral dystrophy (FSHD), a pathology linked to a deletion of subtelomeric repeats on chromosome 4q. More recently, however, the gene has been associated with various sarcomas and haematological malignancies. Drugs developed for FSHD could be tested on cancer cells to develop efficient treatment strategies for both pathologies.
Gene Rearrangement, Homeodomain Proteins, Epigenesis, Genetic, Gene Expression Regulation, Neoplastic, Neoplasms, Humans, Protein Interaction Domains and Motifs, Disease Susceptibility, Molecular Targeted Therapy, Protein Binding
Gene Rearrangement, Homeodomain Proteins, Epigenesis, Genetic, Gene Expression Regulation, Neoplastic, Neoplasms, Humans, Protein Interaction Domains and Motifs, Disease Susceptibility, Molecular Targeted Therapy, Protein Binding
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 14 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
